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 Headache is common. Up to 5% of attendances to emergency 
departments and acute medical units are due to headache. 
Headache is classifi ed as either primary (eg migraine, cluster 
headache) or secondary to another cause (eg meningitis, 
subarachnoid haemorrhage). Even in the acute setting the 
majority of cases are due to primary causes. The role of the 
attending physician is to take a comprehensive history to 
diagnose and treat benign headache syndromes while ruling 
out sinister aetiologies. This brief article summarises the ap-
proach to assessment of headache presenting in acute and 
emergency care. 
 Introduction 
 Headache is the commonest neurological symptom. 1–4% of 
emergency department (ED) attendances are due to headache, 
although only a small minority of these have a serious cause such 
as intracranial haemorrhage or meningitis. 1,2 
 Headaches are classified as either primary or secondary. 3 
Primary headaches, such as migraine, have an independent 
pathophysiology with no other cause and are usually benign 
and recurrent. Secondary headaches are a symptom of another 
disorder. In all settings, including EDs, primary headache disorders 
are much commoner than secondary disorders. 4 
 Assessment of headache in the acute setting 
 Management of headache in the acute setting should focus 
on excluding serious secondary causes, making a positive 
diagnosis, managing symptoms, and establishing a continuing 
care plan. Clinical assessment is based primarily on the history. 
A focused clinical examination helps exclude serious pathology. 
Investigations should be requested only where necessary. Imaging 
is not a substitute for robust clinical assessment. 
 Patients often find it difficult to describe their headache beyond 
its intensity and location. The clinician must ‘ take the history’ and 
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draw out the relevant features. The focus should be on the onset 
and evolution of symptoms. For example, patients may report 
a sudden severe headache, but this is not synonymous with the 
term ‘thunderclap headache’. The most useful initial question is 
‘How long did the headache take to reach its maximum intensity?’ 
Table  1 lists other suggested questions. When considering 
associated features, specifically enquire about features of 
migraine, autonomic dysfunction and raised intracranial pressure. 
Broadly speaking, thunderclap headache and subacute progressive 
headache are more likely to be associated with secondary 
pathology, while recurrent episodic headache and chronic 
headache (>15 days a month for >3 months) are more likely to be 
due to a primary cause. 
 Key points 
 Diagnosis of headache in the acute setting depends primarily on 
the clinician taking a thorough history, supported by a focused 
examination 
 Primary headaches, especially migraine, are common in the 
acute setting – it is important to positively diagnose and treat 
these 
 Bacterial meningitis almost always presents with one of fever, 
neck stiffness and altered mental status in addition to headache 
 A thunderclap headache reaches maximum intensity within 
60 seconds. In such cases, a CT scan of the brain and lumbar 
puncture are necessary to exclude subarachnoid haemorrhage 
 Medication overuse headache should be considered in anyone 
taking frequent analgesia for a primary headache disorder. 
Patients should be given advice on this condition 
 Fewer than 1 in 1,000 people under 50 years presenting with an 
isolated headache will have a brain tumour 
 KEYWORDS :  headache ,  emergency ,  subarachnoid haemorrhage , 
 meningitis ,  migraine ,  cluster headache ■ 
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 Examination should particularly assess for disturbance of 
vital signs, meningism, altered consciousness and obvious focal 
neurological deficit. Take particular care over ocular examination 
for ophthalmoplegia, ptosis, pupillary abnormalities and 
 Table 1.  Useful questions 
 Questions  Notes 
Have you ever had headaches 
before?
‘Yes’ suggests primary headaches more likely, although the patient may have more than one 
headache type
Before the current episode, how 
many times a month (or a year) 
would you get a headache?
Patients with long-standing migraine are often undiagnosed and may discount their typical 
headaches as ‘normal headaches that everyone gets’ unless asked explicitly. Also ask about 
‘menstrual headaches’ and ‘hungry headaches’ as a marker of migraine
Is this your worst ever headache? ‘Yes’ suggests secondary headaches more likely
How long did the headache take to 
reach maximum intensity?
Possibly the most useful question. ‘Sudden onset’ is not sufficiently specific; ‘thunderclap’ 
headache should peak within 1 minute (at most 5 minutes); cluster headache develops over up 
to 30 minutes; migraine develops over hours
What is the duration of headache? Migraine and many secondary headaches are present from hours to days; headaches lasting 
minutes or those present for months or years tend to be more benign
When did you last have a ‘crystal 
clear’ headache-free day?
A useful question in chronic headache (>15 days/month for >3 months), especially when initially 
reported to be constant
When do you get the headaches? Timing of attacks may be helpful – cluster headaches are commoner at night; morning 
headaches may be seen in obstructive sleep apnoea and raised intracranial pressure (ICP)
Are there any triggers for the 
headache?
Eg stress, menstruation, diet, caffeine, alcohol, dehydration and other triggers are associated with 
migraine
Do you have a warning before your 
headache?
Migraine may be heralded by a prodrome of loss of appetite, lethargy, drowsiness or difficulty 
concentrating in the hours before the headache
∼30% have a true aura, lasting less than 60 minutes and includes more focal neurological 
symptoms such as visual scotoma or paraesthesia
Where is the headache? Location is not usually very helpful for diagnosis – most headache disorders may cause headache 
in any location
Strictly unilateral ‘side-locked’ headaches are characteristic of cluster headache and related 
disorders (trigeminal autonomic cephalalgias) but can also occur in migraine
 Associated features 
Nausea or vomiting Migraine or raised intracranial pressure (if severe vomiting always consider raised ICP)
Blurred vision or visual loss Migraine, acute angle-closure glaucoma or raised ICP
Photophobia Migraine, meningism, uveitis
Phonophobia
Migraine
Osmophobia
Motion sensitivity / intolerance / 
aggravation by routine activity
Restlessness / agitation Cluster headache (contrast with the motion intolerance of migraine)
Lacrimation
Trigeminal autonomic cephalalgias such as cluster headache, if unilateral; may also occur in 
migraine (bilateral or unilateral)
Rhinorrhoea
Conjunctival injection
Visual obscurations (transient 
‘graying out’ of vision for seconds, 
particularly on Valsalva manoeuvres) Raised intracranial pressure
Pulsatile tinnitus
 ‘Red flag’ symptoms See Table  2 ‘SNOOP4’
fundoscopy looking for papilloedema which are easily missed and 
may reflect serious pathology. 
 We will discuss serious secondary headache disorders which need 
to be excluded before turning to the primary headaches. 
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 Bacterial meningitis 
 Acute bacterial meningitis presents with headache in 87% of 
cases, usually progressive over hours or days, and generalised. The 
classic triad of neck stiffness, fever and altered mental status is only 
present in 44% of cases. 6 However, meningitis is very unlikely (<1%) 
in a patient with none of the triad. 6 Be careful to distinguish neck 
stiffness from neck pain (present in 75% of migraineurs). 7 Kernig’s 
and Brudzinski’s signs are well known but should not be relied upon 
(sensitivity is as low as 5%). Other features may include nausea, 
seizures, rash in meningococcal disease, and focal neurologic deficits. 
 If meningitis is suspected, take immediate blood cultures and 
give intravenous antibiotics and dexamethasone. As per recent 
UK guidelines, 8 a computed tomography (CT) scan should not 
be performed as it delays lumbar puncture (LP) and treatment, 
except in suspected raised intracranial pressure with risk of brain 
shift (Table  3 ). Serum:CSF glucose ratio <0.36 is the most accurate 
laboratory predictor of bacterial meningitis. 9 Management should 
follow established guidelines. 8 
 Thunderclap headache: subarachnoid haemorrhage 
and other vascular causes 
 Non-traumatic subarachnoid haemorrhage (SAH) is due to rupture 
of an intracranial aneurysm in >80% of cases, with a mortality 
of up to 50%. 10 It only accounts for a small percentage of acute 
headaches seen in ED but must not be missed. Misdiagnosis 
quadruples the risk of death after 1 year. 11 
 Secondary headaches 
 Many secondary causes of headache are clinically obvious (eg 
stroke or acute head trauma). Diagnostic difficulty arises primarily 
where headache is the only symptom, or one of only a few (Fig  1 ). 
The SNOOP4 mnemonic may be used to remember ‘red flags’ 
for serious secondary headaches (Table  2 ). 5 These features and 
diagnoses should be carefully considered in all patients. 
Intracranial
mass lesion
Giant cell
arteris
Acute angle
closure
glaucoma
Meningis and
encephalis
Subarachnoid
haemorrhage
Cerebral
venous sinus
thrombosis
Intracranial
hypertension
or hypotension
Carbon
monoxide
poisoning
Hypertensive
encephalopathy
Cervico-cerebral
artery dissecon
 Fig 1.  Some of the important secondary causes of acute headache. 
 Table 2.  SNOOP4 mnemonic to assess for secondary causes of headache 
 Systemic symptoms and signs  Possible causes 
Fever, rigors, sweats, weight loss Infection, giant cell arteritis, neoplasia
History of immunosuppression or cancer
Pregnancy Secondary vascular cause, especially cerebral venous sinus thrombosis
Family history of intracranial aneurysm Subarachnoid haemorrhage
Obesity Idiopathic intracranial hypertension
 Neurological symptoms and signs 
Focal neurological deficit Any secondary cause (migraine aura may also cause focal deficit, but 
this evolves over minutes and usually resolves within 1 hour)
Meningism Infection, subarachnoid haemorrhage
Visual obscurations, pulsatile tinnitus Idiopathic intracranial hypertension, mass lesions
 Onset sudden 
Did the pain reach maximum intensity within 60 seconds 
(thunderclap headache)?
Secondary vascular causes
 Onset for the first time over 50 years age Any secondary cause (especially giant cell arteritis)
 Progressive headache (in intensity or duration of episodes) Consider possibility of neoplasia or medication-overuse headache
 Precipitated by Valsalva manoeuvre Chiari malformation, intracranial structural lesion – especially posterior 
fossa; intracranial hypotension
 Postural relationship 
Worse when standing Intracranial hypotension
Worse when lying Raised intracranial pressure
 Papilloedema Raised intracranial pressure
 Secondary causes include intracranial infection, inflammation including giant cell arteritis, neoplasia and vascular disease. Vascular disease includes stroke, 
subarachnoid haemorrhage, venous sinus thrombosis, reversible cerebral vasoconstriction syndrome and arterial dissection. Adapted from Dodick. 5 
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 The classical presentation is of a ‘thunderclap’ headache 
(time to maximal intensity within 60 seconds). A ‘worst ever’ 
thunderclap headache, occurring on exertion is found in 70–85% 
of people with SAH and 3–10% of other new headaches in ED. 12 
Only 5% of SAH headaches resolve within 24 hours – the diagnosis 
is very unlikely when resolution occurs within 1 hour without 
treatment. 13 However, resolution of headache with analgesia 
should not be taken to indicate a benign cause. The Ottawa 
SAH rule has been proposed to triage patients for investigation 
(Table  4 ). 14 
 Investigation of suspected SAH requires urgent brain CT 
imaging – sensitivity decreases with time. Non-contrast CT is 
reported to be >97% sensitive within 6 hours when interpreted 
by an experienced neuroradiologist. In routine practice, up 
to 20% of cases may be missed on multi-slice helical CT 
imaging within 6 hours. 15 Therefore, if the scan is negative, 
an LP must be performed >12 hours after headache onset for 
spectrophotometric assessment of xanthochromia. 16 If LP 
is normal, then SAH is excluded up to 2 weeks after onset. 17 
Following diagnosis, CT or magnetic resonance (MR) angiography 
(CTA; MRA) is performed. If no aneurysm is found despite the 
presence of SAH, then catheter angiography remains the gold 
standard. 16 CTA should not be used for diagnosis as ∼3% of the 
population have an intracranial aneurysm. 18 
 Only 11–25% of thunderclap headaches are due to SAH. The 
differential diagnosis includes other vascular headaches. Carotid 
artery dissection (particularly suggested by preceding neck 
trauma, or Horner’s syndrome) and vertebrobasilar dissection 
(occipital or neck pain and nausea or vertigo) may present with 
acute headache, 19 often before the onset of subsequent stroke. 
Diagnosis is by CT/MR/catheter angiography. 
 Cerebral venous sinus thrombosis particularly affects women, 
especially in pregnancy and peripartum. Headache is present in 
90%, often as the first symptom, and is often gradual but may be 
‘thunderclap’ in 10%. Features of raised intracranial pressure may 
occur, as may seizures (40%) and focal neurologic deficits (20%). 20 
Diagnosis is by CT/MR venography. 
 Reversible cerebral vasoconstriction syndrome (RCVS) is an 
increasingly recognised, although poorly understood, disorder. 
It is usually characterised by recurrent thunderclap headaches 
associated with reversible constriction of cerebral arteries. There 
may be an identifiable trigger event. The thunderclap headaches 
occur several times over weeks, with each episode lasting just 
minutes to hours, in contrast to SAH. 21 Strokes and seizures, 
although unusual, sometimes occur. Initial brain imaging is often 
normal. Diagnosis is confirmed by angiography and treatment is 
supportive. 
 Other causes of thunderclap headache with normal routine 
imaging include pituitary apoplexy, hypertensive encephalopathy 
and spontaneous intracranial hypotension. 
 Other serious secondary headaches 
 Giant cell arteritis (GCA) should be considered in all adults 
>50 years of age with new chronic headache, especially if 
there is systemic malaise. Headache in GCA is only infrequently 
temporal. 22 Scalp tenderness is not specific and occurs in many 
headaches, including migraine. Jaw and tongue claudication are 
specific but occur in < 50%. Full blood count (FBC), erythrocyte 
sedimentation rate (ESR)  and C-reactive protein (CRP) should be 
performed. If suspected, start high dose steroids and arrange 
confirmatory temporal artery biopsy later. 
 Up to 6% of ED attendees with headache may have carbon 
monoxide toxicity. 23 A high index of suspicion is needed. Toxicity 
causes non-specific headache, dizziness, nausea and confusion. 
‘Cherry red’ skin and lip discoloration are rare. 24 Blood gas 
measurement of carboxyhaemoglobin is confirmatory. Treatment 
is with 100% high-flow oxygen. 24 
 Acute angle-closure glaucoma may present, particularly in the 
elderly, primarily as frontal headache with nausea and halo-
like visual phenomena. It is thus sometimes misdiagnosed as 
migraine. 25 The pupil may be fixed or irregular with conjunctival 
injection. 25 If suspected, intraocular pressure measurement is 
diagnostic. 
 Although headaches occur in >50% of adults with malignant 
brain tumours, 26 they are the sole presenting symptom in just 
2%. 27 Conversely, 0.08% of adults under 50 years with a new 
headache will have a tumour, rising to 0.28% over 50 years. 26 
 Table 3.  Indications for neuroimaging before lumbar 
puncture in suspected bacterial meningitis 
Indications for neuroimaging before LP 
Focal neurologic signs
Presence of papilloedema
Continuous or uncontrolled seizures
GCS <12
 Inability to view the fundus and GCS<12 are not absolute contraindications. 
Taken from the UK joint specialist societies’ guideline on the diagnosis 
and management of acute meningitis and meningococcal sepsis in 
immunocompetent adults. 8 
 GCS = Glasgow Coma Scale 
 Table 4.  Ottawa subarachnoid haemorrhage rule 
for investigation of new non-traumatic severe 
headaches 
Inclusion criteria 
Age >15 years
New severe headache with maximum intensity within 1 hour
No known brain tumour, intracranial aneurysm or previous SAH
No previous chronic or recurrent headaches (3 or more similar 
headaches in last 6+ months)
Criteria for further investigations of headache
Age >40 years
Thunderclap headache
Headache onset during exertion
Neck pain or stiffness
Witnessed loss of consciousness
Limited neck flexion on examination
 Patients must fulfil all inclusion criteria before the rule can be applied. Then if 
any of the criteria for further investigations are positive, a CT scan of the brain 
is indicated. Applied as stated, sensitivity up to 100%, with specificity 15%. 
Taken from Perry  et al . 14 
 CT = computed tomography; SAH = subarachnoid haemorrhage 
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Most patients also have seizures, focal neurologic deficits or 
altered mental status. 27 Headache characteristics are variable, 
but may manifest raised pressure features. Fundoscopy to exclude 
papilloedema is therefore mandatory in all chronic headache 
patients. In obese, young women with raised increased intracranial 
pressure (ICP) headache and papilloedema with normal imaging, 
consider idiopathic intracranial hypertension (venous sinus 
thrombosis should first be excluded in this context). 
 Primary headaches 
 ‘Headache’ is a symptom, not a diagnosis. Where there is no 
clinically suspected secondary headache, a primary headache 
diagnosis should be sought and actively managed. The most 
prevalent primary headaches are migraine (∼15%), tension type 
headache (∼60%) and cluster headache (∼0.1%). 
 Migraine is one of the top 10 causes of disability worldwide 28 
with 8–14% of sufferers presenting to ED at some time. It is 
characterised by photophobia, phonophobia, osmophobia and 
motion intolerance, with moderate to severe throbbing pain 
and nausea and/or vomiting. 3 However, these distinguishing 
features may diminish when symptoms become chronic, leaving 
unremitting pain and high disability. Only one-third of patients 
experience aura. 29 In practice, most episodic, recurrent disabling 
headache is due to migraine. 
 Migraine is under-reported by patients and under-diagnosed. 
Effective acute treatment of episodic migraine reduces the risk of 
progression to chronic migraine. 30 Initial management in ED may 
be with combination therapy of a triptan and high-dose NSAID 
(eg 900 mg aspirin or 500 mg naproxen). 31 Dopamine antagonist 
antiemetics (domperidone or metoclopramide) can be used with 
analgesia and have an independent action on acute migraine and 
migraine-associated gastroparesis. Opiates should be avoided. 
Establish follow-up with primary care or neurology services for 
consideration of longer-term prophylaxis. 32 
 By contrast, tension-type headache (TTH) is a featureless 
bilateral headache which is not disabling acutely. This is rarely the 
diagnosis in ED patients. When suspected, further elaboration of 
the history typically reveals the diagnosis to be migraine. 
 Cluster headache manifests as excruciating, strictly unilateral 
headache with prominent ipsilateral autonomic dysfunction. 
Migraine is unilateral in 60% of cases, 29 and may also show 
autonomic disturbance. However, cluster attacks typically last 
30 minutes to, at most, 4 hours, while untreated migraine in 
adults lasts >4 hours and sometimes days. Moreover, patients 
with cluster headache are typically very restless while migraineurs 
are motion intolerant. Acute treatment is with sumatriptan 6 mg 
subcutaneous injections or 100% oxygen delivered through 
a non-rebreathing face mask. Standard analgesics (including 
oral triptans) are rarely effective. A tapering course of high-
dose prednisolone may be initiated. Verapamil is the first line 
prophylactic but should be initiated under specialist guidance. 33 
 Medication overuse headache 
 Medication overuse headache (MOH) is a common complication 
of primary headache disorders (prevalence is 1%), leading to 
chronic headache. 3 It is diagnosed when medications such 
as triptans, opioids and combination analgesics are used on 
>10 days/month or NSAIDs or paracetamol on >15 days/month. 
MOH resembles the underlying primary headache type, but is 
refractory to preventative medications until analgesic overuse is 
rectified. The number of days a painkiller is used is more important 
than the overall dose taken per day. 
 Following diagnosis of a primary headache disorder in the acute 
setting establish continuity of care to help prevent re-presentation. 
Encourage the patient to keep a headache diary including 
frequency, duration and timing of attacks. Patients with migraine 
or TTH should be warned explicitly about prevention of MOH. ■ 
 Further reading 
 UK guidelines on management of headache are available from 
NICE. 31 We particularly recommend the detailed guidelines on the 
management of primary headaches available online from the British 
Association for the Study of Headache. 32 
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